First Mercantile Trust Co. acquired a new position in Encompass Health Corp (AMEX:EHC) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 2,480 shares of the company’s stock, valued at approximately $142,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. O Shaughnessy Asset Management LLC purchased a new position in shares of Encompass Health in the first quarter worth about $144,000. FNY Managed Accounts LLC purchased a new position in shares of Encompass Health in the fourth quarter worth about $125,000. Cerebellum GP LLC purchased a new position in shares of Encompass Health in the fourth quarter worth about $129,000. Migdal Insurance & Financial Holdings Ltd. purchased a new position in shares of Encompass Health in the first quarter worth about $219,000. Finally, Motley Fool Wealth Management LLC purchased a new position in shares of Encompass Health in the first quarter worth about $249,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.
A number of research analysts recently issued reports on EHC shares. Wells Fargo started coverage on Encompass Health in a report on Tuesday, January 30th. They set a “market perform” rating and a $56.00 price target on the stock. Zacks Investment Research upgraded Encompass Health from a “hold” rating to a “buy” rating and set a $60.00 price target on the stock in a report on Tuesday, January 30th. Credit Suisse Group boosted their price target on Encompass Health from $58.00 to $61.00 and gave the company an “outperform” rating in a report on Tuesday, February 27th. Stephens set a $62.00 price target on Encompass Health and gave the company a “buy” rating in a report on Tuesday, February 27th. Finally, Royal Bank of Canada boosted their price target on Encompass Health to $64.00 and gave the company an “outperform” rating in a report on Thursday, March 1st. One investment analyst has rated the stock with a sell rating, five have given a hold rating and eight have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $64.10.
In other news, insider Cheryl B. Levy sold 30,982 shares of the business’s stock in a transaction that occurred on Wednesday, May 9th. The stock was sold at an average price of $63.00, for a total value of $1,951,866.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Mark J. Tarr sold 33,100 shares of the business’s stock in a transaction that occurred on Tuesday, May 1st. The stock was sold at an average price of $60.96, for a total value of $2,017,776.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 69,777 shares of company stock worth $4,326,032. Insiders own 1.60% of the company’s stock.
Encompass Health opened at $57.67 on Monday, MarketBeat reports. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89. Encompass Health Corp has a fifty-two week low of $40.86 and a fifty-two week high of $59.29.
Encompass Health (AMEX:EHC) last posted its quarterly earnings data on Thursday, April 26th. The company reported $0.93 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.81 by $0.12. The business had revenue of $1.05 billion for the quarter, compared to analysts’ expectations of $1.04 billion. Encompass Health had a return on equity of 23.56% and a net margin of 8.67%. Encompass Health’s revenue was up 10.0% on a year-over-year basis. equities research analysts expect that Encompass Health Corp will post 2.72 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, July 16th. Shareholders of record on Monday, July 2nd will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, June 29th. This represents a $1.00 annualized dividend and a yield of 1.73%.
Encompass Health Company Profile
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corp (AMEX:EHC).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.